Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
24 November 2020
Congratulations to Dr James Wilmott and everyone involved in this important work, which today won the 2020 Wildfire Highly Cited Publication Award.
“Our research really highlighted that melanoma is not one large cancer type. It’s actually made up of different molecular phenotypes relating to where the melanoma originates,” Dr James Wilmott
Whole-genome landscapes of major melanoma subtypes was published in 2017 in Nature, an international journal featuring peer-reviewed research in scientific technology. The project was led by Dr James Wilmott and is a collaboration across Melanoma Institute Australia (MIA), QIMR Berghofer Medical Research Institute, and The University of Sydney, and had about 50 co-authors.
Tissue samples from 183 Australian patients were sourced from biobanks, including the MIA and Peter MacCallum Cancer Centre in Victoria.
This vital study will help improve outcomes for people with melanoma. It has been cited an amazing 362 times around the world since it was published.
Dr Wilmott and his team have received international recognition for their research in the clinical implications of genomic profiling, and the progress they have made so far keeps them motivated.
“We will keep working on finding cures for melanoma patients.” Dr James Wilmott
Find out more about the study and how it came together: Cancer Institute NSW Wildfire Highly Cited Publication Award background
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.